Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers

Open access
Salem, Mohamed E., Weinberg, Benjamin A., Xiu, Joanne, El-Deiry, Wafik S., Hwang, Jimmy J., Gatalica, Zoran, Philip, Philip A., Shields, Anthony F., Lenz, Heinz-Josef, Marshall, John L. · 2017 · Oncotarget

Abstract

// Mohamed E. Salem 1, * , Benjamin A. Weinberg 1, * , Joanne Xiu 2 , Wafik S. El-Deiry 3 , Jimmy J. Hwang 4 , Zoran Gatalica 2 , Philip A. Philip 5 , Anthony F. Shields 5 , Heinz-Josef Lenz 6 and John L. Marshall 1 1 Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA 2 Caris Life Sciences, Phoenix, AZ, USA 3 Fox Chase Cancer Center, Philadelphia, PA, USA 4 Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA 5 Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA 6 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA * Co-first authors Correspondence to: Mohamed E. Salem, email: mohamed.e.salem@gunet.georgetown.edu Keywords: colorectal neoplasms, colonic neoplasms, rectal neoplasms, DNA mutational analysis, immunohistochemistry Received: June 01, 2017 Accepted: August 15, 2017 Published: September 21, 2017 ABSTRACT Tumor sidedness has emerged as an important prognostic and predictive factor in the treatment of colorectal cancer. Recent studies demonstrate that patients with advanced right-sided colon cancers have a worse prognosis than those with left-sided colon or rectal cancers, and these patient subgroups respond differently to biological therapies. Historically, management of patients with metastatic colon and rectal cancers has been similar, and colon and rectal cancer patients have been grouped together in large clinical trials. Clearly, the differences in molecular biology among right-sided colon, left-sided colon, and rectal cancers should be further studied in order to account for disparities in clinical outcomes. We profiled 10,570 colorectal tumors (of which 2,413 were identified as arising from the left colon, right colon, or rectum) using next-generation sequencing, immunohistochemistry, chromogenic in-situ hybridization, and fragment analysis (Caris Life Sciences, Phoenix, AZ). Right-sided colon cancers had higher rates of microsatellite instability, more frequent aberrant activation of the EGFR pathway including higher BRAF and PIK3CA mutation rates, and increased mutational burden compared to left-sided colon and rectal cancers. Rectal cancers had higher rates of TOPO1 expression and Her2/neu amplification compared to both left- and right-sided colon cancers. Molecular variations among right-sided colon, left-sided colon, and rectal tumors may contribute to differences in clinical behavior. The site of tumor origin (left colon, right colon, or rectum) should certainly be considered when selecting treatment regimens and stratifying patients for future clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.21169

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 216

Metadata

Authors
Salem, M. E., Weinberg, B. A., Xiu, J., El-Deiry, W. S., Hwang, J. J., Gatalica, Z., Philip, P. A., Shields, A. F., Lenz, H.-J., & Marshall, J. L.
Venue
Oncotarget
Published
2017-09-21
Volume
8
Issue
49
Pages
86356-86368
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2760130725
Cited by
216
References
14
FWCI
9.16
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. https://app.cochat.ai/papers/10.18632/oncotarget.21169
The paper
Salem, M. E., Weinberg, B. A., Xiu, J., El-Deiry, W. S., Hwang, J. J., Gatalica, Z., Philip, P. A., Shields, A. F., Lenz, H.-J., & Marshall, J. L. (2017). Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget. https://doi.org/10.18632/oncotarget.21169

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.